Your dog was diagnosed with Pituitary Macroadenoma / Macrocarcinoma. Pituitary tumours are the most common cause of pituitary-dependent hyperadrenocorticism (Cushing's disease) in dogs. Macroadenomas (>10mm) can cause neurological signs by compression of surrounding brain tissue. Most are functional (ACTH-secreting). Compare 3 treatment options for dogs including Radiation Therapy, Transsphenoidal Hypophysectomy, Medical Management (Trilostane) + Monitoring — with survival times, costs, and what to expect during treatment.
Pet Cancer Options — Pituitary Macroadenoma / Macrocarcinoma
Canine Oncology Treatment Guide
Pituitary Macroadenoma / Macrocarcinoma
Neuroendocrine
About This Cancer
The pituitary gland, located at the base of the brain, is a small but critically important 'master gland' that controls hormonal systems throughout the body. Pituitary tumours in dogs are usually functional adenomas that secrete excess ACTH, leading to Cushing's disease (hyperadrenocorticism) — a condition characterised by increased drinking and urination, pot-bellied appearance, hair loss, and skin changes. When the tumour grows large enough (macroadenoma, typically >10 mm), it can press on surrounding brain structures, causing neurological signs such as lethargy, circling, or blindness. While the hormonal effects of Cushing's disease can be managed medically, the growing tumour mass itself requires different treatment — typically radiation therapy to shrink the tumour, or in specialised centres, surgical removal via the transsphenoidal approach.
Pituitary tumour size classification
Based on MRI measurements relative to brain area. Microadenoma vs macroadenoma threshold varies by source (~10mm or pituitary height/brain area ratio >0.31).
Prognostic Factors(2)
Minimum Workup(6 steps)
Median Survival Time Comparison
How long the average patient survives with each treatment
Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.
Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.